$20.87

+0.29 (+1.41%)

Weekly Expected Move ±2.4%

$20 $20 $21 $21 $22

NASDAQ · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 37 · $1.4B mcap · 68M float · 1.06% daily turnover · Short 49% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

36.8 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 31.7% · 5Y Avg: 14.4%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HCSG has No discernible competitive edge (36.8/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 31.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$28

Low

$28

Avg Target

$28

High

Based on 1 analyst since Jul 22, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 6Hold: 7Sell: 2Strong Sell: 0

Rating Summary

ConsensusHold

Avg Target$29.00

Analysts2

Consensus Change History

Date	Field	From	To
2026-04-23	consensus	Buy	Hold

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-08-19	Oppenheimer	—	Initiated	$28	—	+27.6%	$21.94
2026-07-08	UBS	—	$27	$30	+3	+24.0%	$24.20
2026-04-23	RBC Capital	—	$20	$24	+4	+8.7%	$22.08
2026-04-23	UBS	—	$25	$27	+2	+22.3%	$22.08
2026-04-23	BMO Capital	—	$22	$24	+2	+4.8%	$22.89
2026-02-12	UBS	—	$22	$25	+3	+18.2%	$21.15
2026-02-12	BMO Capital	—	Initiated	$22	—	+1.5%	$21.68
2026-02-12	Robert W. Baird	—	$13	$23	+10	+8.0%	$21.30
2025-10-28	UBS	—	Initiated	$22	—	+16.7%	$18.85
2025-04-24	Robert W. Baird	Andrew Wittmann	$14	$13	-1	+1.8%	$12.77
2024-07-25	Robert W. Baird	Andrew Wittmann	Initiated	$14	—	+26.4%	$11.07
2022-04-21	Credit Suisse	—	Initiated	$18	—	-9.6%	$19.91
2022-04-20	RBC Capital	Sean Dodge	Initiated	$20	—	-0.4%	$20.09

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HCSG receives an overall rating of A-. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/B (2/5).

Rating Change History

Date	From	To
2026-10-01	A	A-
2026-08-18	A-	A
2026-08-17	A	A-
2026-07-25	A+	A
2026-07-22	A-	A+
2026-06-16	A	A-
2026-05-26	A-	A
2026-03-20	B+	A-
2026-03-18	A-	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 73 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HCSG scores highest in Safety (100/100) and lowest in Profitability (46/100). An overall grade of A+ places HCSG among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

7.41

Safe Zone

Piotroski F-Score

8/9

✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓ ✓

Beneish M-Score

-3.24

Unlikely Manipulator

Ohlson O-Score

-9.84

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AAA

Score: 96.1/100

Trend: Improving

Earnings Quality

100/100

OCF/NI: 1.28x

Accruals: -4.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HCSG scores 7.41, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HCSG scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HCSG's score of -3.24 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HCSG's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HCSG receives an estimated rating of AAA (score: 96.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). HCSG's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

12.06x

PEG

0.01x

P/S

0.77x

P/B

2.79x

P/FCF

11.43x

P/OCF

11.01x

EV/EBITDA

10.28x

EV/Revenue

0.83x

EV/EBIT

10.85x

EV/FCF

10.22x

Earnings Yield

7.10%

FCF Yield

8.75%

Shareholder Yield

5.30%

Graham Number

$17.00

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 12.1x earnings, HCSG trades at a reasonable valuation. An earnings yield of 7.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $17.00 per share, 23% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.812

NI / EBT

Interest Burden

1.061

EBT / EBIT

EBIT Margin

0.077

EBIT / Rev

Asset Turnover

2.298

Rev / Assets

Equity Multiplier

1.630

Assets / Equity

ROE

24.7%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HCSG's ROE of 24.7% is driven by Asset Turnover (2.298), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$67.16

Price/Value

0.37x

Margin of Safety

63.43%

Premium

-63.43%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with HCSG's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. HCSG actually compounded EPS at 52.9% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. HCSG trades at a -63% premium to its adjusted intrinsic value of $67.16, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 12.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$20.87

Median 1Y

$19.09

5th Pctile

$9.97

95th Pctile

$36.54

Ann. Volatility

43.6%

Analyst Target

$29.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Theodore Wahl & resident & Chief Executive Officer & Director	$1,005,108	$2,475,457	$4,725,723
Andrew W. Kush Executive Vice President & Chief Operating Officer	$651,288	$510,164	$1,583,287
John C. Shea Executive Vice President & Chief Administrative Officer	$618,371	$521,042	$1,468,431
Patrick J. Orr Executive Vice President & Chief Revenue Officer	$591,304	$477,587	$1,427,759
Vikas Singh & xecutive Vice President & Chief Financial Officer	$578,998	$508,000	$1,314,831

CEO Pay Ratio

891:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $4,725,723

Avg Employee Cost (SGA/emp): $5,302

Employees: 36,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

36,000

+2.0% YoY

Revenue / Employee

$51,033

Rev: $1,837,173,000

Profit / Employee

$1,641

NI: $59,059,000

SGA / Employee

$5,302

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	15.1%	9.8%	6.9%	6.4%	4.6%	7.9%	7.9%	8.2%	7.1%	8.4%	8.9%	6.6%	10.8%	8.3%	8.4%	2.3%	8.1%	11.7%	13.2%	24.7%	24.69%
ROA	9.2%	5.8%	4.3%	3.8%	2.7%	4.6%	4.8%	4.8%	4.2%	4.9%	5.3%	3.9%	6.4%	4.9%	5.1%	1.3%	4.9%	7.3%	8.3%	15.2%	15.15%
ROIC	24.4%	15.7%	9.4%	8.9%	5.9%	10.1%	9.1%	8.7%	7.7%	10.2%	10.5%	8.5%	12.2%	10.4%	9.7%	2.8%	9.5%	14.5%	16.7%	31.7%	31.72%
ROCE	15.1%	10.6%	8.1%	7.1%	5.3%	8.9%	8.9%	9.4%	8.5%	10.2%	10.9%	8.8%	12.6%	9.5%	9.7%	3.3%	9.3%	10.9%	12.8%	22.5%	22.55%
Gross Margin	12.2%	10.3%	12.5%	10.7%	9.1%	13.5%	14.9%	14.9%	8.2%	17.3%	15.2%	9.7%	14.8%	13.4%	15.2%	0.6%	20.8%	16.3%	16.4%	15.9%	15.89%
Operating Margin	2.8%	0.4%	3.3%	2.3%	0.2%	4.7%	3.2%	2.4%	-1.3%	7.4%	5.1%	-0.4%	4.4%	3.3%	4.8%	-9.1%	10.7%	5.5%	7.3%	4.7%	4.72%
Net Margin	2.3%	0.5%	2.7%	1.6%	0.1%	3.8%	2.8%	2.0%	-1.3%	5.3%	3.6%	-0.4%	3.3%	2.7%	3.8%	-7.1%	9.3%	6.7%	5.6%	4.8%	4.82%
EBITDA Margin	3.9%	1.4%	4.8%	2.9%	1.3%	5.9%	5.2%	3.9%	-0.2%	8.7%	6.3%	0.8%	5.6%	4.5%	6.3%	-8.0%	13.3%	7.0%	8.3%	3.8%	3.76%
FCF Margin	4.6%	1.9%	-0.2%	-1.1%	-0.3%	-0.8%	0.1%	-0.0%	0.7%	2.3%	1.6%	2.1%	2.2%	1.4%	4.5%	5.1%	8.7%	7.6%	8.4%	8.1%	8.12%
OCF Margin	4.9%	2.3%	0.2%	-0.8%	0.0%	-0.5%	0.3%	0.2%	1.0%	2.6%	2.0%	2.5%	2.6%	1.8%	4.8%	5.5%	9.1%	7.9%	8.7%	8.4%	8.43%
ROE 3Y Avg	snapshot only																				10.82%
ROE 5Y Avg	snapshot only																				9.47%
ROA 3Y Avg	snapshot only																				6.72%
ROIC 3Y Avg	snapshot only																				14.52%
ROIC Economic	snapshot only																				21.33%
Cash ROA	snapshot only																				19.15%
Cash ROIC	snapshot only																				46.83%
CROIC	snapshot only																				45.12%
NOPAT Margin	snapshot only																				5.71%
Pretax Margin	snapshot only																				8.12%
R&D / Revenue	snapshot only																				0.00%
SGA / Revenue	snapshot only																				10.30%
SBC / Revenue	snapshot only																				0.61%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	24.54	27.26	40.66	42.18	43.00	25.77	29.55	30.58	25.36	20.69	22.73	25.51	16.47	21.78	18.01	102.05	31.13	23.19	19.41	14.08	12.064
P/S Ratio	1.07	0.76	0.80	0.74	0.52	0.53	0.61	0.66	0.46	0.46	0.55	0.46	0.49	0.50	0.43	0.62	0.68	0.75	0.71	0.93	0.768
P/B Ratio	3.65	2.76	2.96	2.87	2.10	2.09	2.35	2.47	1.76	1.68	1.95	1.66	1.69	1.72	1.45	2.31	2.49	2.68	2.57	3.34	2.788
P/FCF	23.11	39.80	-469.19	-65.89	-166.62	-66.71	1133.29	-1804.35	65.15	20.11	34.03	21.79	21.90	35.14	9.50	12.14	7.83	9.84	8.46	11.43	11.428
P/OCF	21.56	33.70	386.43	—	2790.98	—	180.54	270.87	45.77	17.61	27.38	18.31	18.75	27.91	8.84	11.40	7.55	9.45	8.18	11.01	11.011
EV/EBITDA	14.09	13.91	19.60	21.01	18.26	12.68	14.94	15.18	11.44	8.95	10.67	10.45	8.28	10.01	8.48	26.96	14.79	13.81	11.97	10.28	10.280
EV/Revenue	0.95	0.66	0.72	0.68	0.48	0.48	0.57	0.62	0.43	0.40	0.50	0.41	0.44	0.43	0.37	0.54	0.60	0.65	0.62	0.83	0.830
EV/EBIT	16.21	17.13	26.06	29.05	27.92	16.73	19.42	19.37	14.86	11.10	12.99	13.31	9.88	12.47	10.58	49.83	19.11	17.14	14.48	10.85	10.849
EV/FCF	20.56	34.47	-426.82	-60.16	-151.62	-60.10	1058.13	-1690.43	59.72	17.39	31.12	19.28	20.05	30.26	8.14	10.51	6.84	8.56	7.41	10.22	10.219
Earnings Yield	4.1%	3.7%	2.5%	2.4%	2.3%	3.9%	3.4%	3.3%	3.9%	4.8%	4.4%	3.9%	6.1%	4.6%	5.6%	1.0%	3.2%	4.3%	5.2%	7.1%	7.10%
FCF Yield	4.3%	2.5%	-0.2%	-1.5%	-0.6%	-1.5%	0.1%	-0.1%	1.5%	5.0%	2.9%	4.6%	4.6%	2.8%	10.5%	8.2%	12.8%	10.2%	11.8%	8.8%	8.75%
PEG Ratio	snapshot only																				0.011
Price/Tangible Book	snapshot only																				4.122
EV/OCF	snapshot only																				9.846
EV/Gross Profit	snapshot only																				4.790
Acquirers Multiple	snapshot only																				11.803
Shareholder Yield	snapshot only																				5.30%
Graham Number	snapshot only																				$17.00

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	3.68	2.86	3.01	2.84	2.82	2.85	3.15	2.90	2.84	2.64	2.77	2.74	2.93	2.89	2.89	2.49	2.97	3.38	3.11	3.02	3.022
Quick Ratio	3.51	2.72	2.87	2.71	2.69	2.73	3.02	2.79	2.74	2.55	2.69	2.65	2.85	2.80	2.81	2.49	2.88	3.28	3.03	2.94	2.938
Debt/Equity	0.02	0.04	0.05	0.05	0.08	0.08	0.10	0.11	0.13	0.10	0.11	0.09	0.07	0.03	0.02	0.03	0.04	0.05	0.03	0.03	0.034
Net Debt/Equity	-0.40	-0.37	-0.27	-0.25	-0.19	-0.21	-0.16	-0.16	-0.15	-0.23	-0.17	-0.19	-0.14	-0.24	-0.21	-0.31	-0.32	-0.35	-0.32	-0.35	-0.353
Debt/Assets	0.01	0.02	0.03	0.03	0.05	0.05	0.06	0.07	0.08	0.05	0.06	0.05	0.04	0.02	0.01	0.02	0.02	0.03	0.02	0.02	0.022
Debt/EBITDA	0.11	0.23	0.34	0.36	0.77	0.52	0.67	0.75	0.91	0.59	0.64	0.61	0.37	0.22	0.11	0.43	0.27	0.29	0.15	0.12	0.118
Net Debt/EBITDA	-1.75	-2.15	-1.95	-2.00	-1.81	-1.39	-1.06	-1.02	-1.04	-1.40	-1.00	-1.36	-0.76	-1.61	-1.42	-4.20	-2.16	-2.08	-1.70	-1.22	-1.216
Interest Coverage	72.48	45.64	30.07	23.92	13.59	16.09	11.75	9.45	6.80	7.59	8.03	6.57	10.45	9.22	12.48	5.41	20.15	34.72	40.46	91.93	91.928
Equity Multiplier	1.65	1.74	1.67	1.69	1.71	1.69	1.63	1.69	1.70	1.76	1.69	1.70	1.65	1.63	1.60	1.68	1.62	1.58	1.59	1.58	1.582
Cash Ratio	snapshot only																				1.068
Debt Service Coverage	snapshot only																				97.018
Cash to Debt	snapshot only																				11.330
FCF to Debt	snapshot only																				8.543
Defensive Interval	snapshot only																				997.9 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	2.13	2.08	2.17	2.17	2.23	2.25	2.29	2.23	2.27	2.20	2.20	2.16	2.19	2.12	2.14	2.21	2.25	2.26	2.26	2.30	2.298
Inventory Turnover	46.80	49.13	53.78	58.00	60.97	63.43	65.63	66.89	69.49	72.62	75.42	77.79	80.52	84.46	85.42	176.87	92.41	95.02	96.55	194.66	194.661
Receivables Turnover	5.80	5.98	5.81	5.60	5.29	5.36	5.02	4.71	4.67	4.64	4.43	4.33	4.40	4.80	4.67	4.90	5.20	5.71	5.81	5.80	5.797
Payables Turnover	26.62	24.26	25.97	25.38	25.55	22.55	23.03	22.03	21.09	19.00	21.03	21.35	19.82	18.10	19.89	21.04	19.99	20.11	19.78	18.80	18.798
DSO	63	61	63	65	69	68	73	78	78	79	82	84	83	76	78	74	70	64	63	63	63.0 days
DIO	8	7	7	6	6	6	6	5	5	5	5	5	5	4	4	2	4	4	4	2	1.9 days
DPO	14	15	14	14	14	16	16	17	17	19	17	17	18	20	18	17	18	18	18	19	19.4 days
Cash Conversion Cycle	57	53	56	57	61	58	62	66	66	64	70	72	69	60	64	59	56	50	48	45	45.4 days
Fixed Asset Turnover	snapshot only																				62.315
Operating Cycle	snapshot only																				64.8 days
Cash Velocity	snapshot only																				9.283
Capital Intensity	snapshot only																				0.440

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	-7.8%	-6.7%	-3.4%	1.4%	2.5%	2.9%	1.2%	-0.8%	-0.9%	-1.1%	-0.2%	0.6%	1.8%	2.7%	3.7%	5.2%	6.3%	7.1%	6.5%	5.2%	5.22%
Net Income	-20.4%	-53.5%	-68.5%	-66.8%	-71.2%	-24.5%	7.5%	22.2%	48.7%	6.9%	16.3%	-15.9%	63.9%	6.6%	1.8%	-64.7%	-20.8%	49.6%	64.0%	10.4%	10.37%
EPS	-20.7%	-53.2%	-68.1%	-66.4%	-70.9%	-24.5%	7.2%	21.8%	48.6%	7.6%	17.0%	-15.1%	64.9%	6.4%	1.9%	-64.5%	-20.3%	54.5%	70.8%	10.8%	10.85%
FCF	-49.7%	-85.2%	-1.0%	-1.1%	-1.1%	-1.4%	1.3%	96.8%	3.2%	3.8%	28.8%	59.1%	2.2%	-35.8%	1.9%	1.5%	3.2%	4.7%	98.5%	66.7%	66.67%
EBITDA	-18.8%	-46.2%	-59.4%	-59.8%	-60.2%	-18.6%	5.2%	25.8%	41.0%	16.7%	22.7%	-3.7%	46.8%	-0.0%	-5.0%	-46.5%	-20.0%	16.6%	28.0%	3.3%	3.25%
Op. Income	-19.4%	-52.2%	-68.3%	-68.4%	-72.0%	-26.7%	4.3%	17.9%	45.9%	11.7%	31.5%	5.0%	84.6%	7.6%	-7.9%	-71.4%	-37.7%	3.4%	26.9%	8.9%	8.95%
OCF Growth	snapshot only																				62.40%
Asset Growth	snapshot only																				2.33%
Equity Growth	snapshot only																				8.76%
Debt Growth	snapshot only																				15.49%
Shares Change	snapshot only																				-4.00%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	-6.5%	-6.5%	-5.7%	-4.6%	-3.7%	-2.8%	-2.5%	-2.4%	-2.1%	-1.7%	-0.8%	0.4%	1.1%	1.5%	1.6%	1.6%	2.3%	2.8%	3.3%	3.6%	3.65%
Revenue 5Y	1.5%	1.0%	1.0%	0.3%	-0.9%	-2.0%	-3.1%	-3.5%	-3.6%	-3.6%	-3.3%	-2.8%	-2.1%	-1.4%	-0.8%	-0.4%	0.3%	0.9%	1.5%	2.3%	2.29%
EPS 3Y	-0.5%	-18.0%	-29.3%	-29.4%	-35.6%	-18.7%	-22.6%	-23.2%	-30.0%	-27.6%	-26.3%	-29.7%	-10.7%	-4.7%	8.5%	-28.4%	25.0%	21.0%	26.7%	52.9%	52.88%
EPS 5Y	1.1%	-10.1%	-16.7%	-18.9%	-25.2%	-17.0%	-12.0%	-12.2%	-15.7%	-14.8%	-15.0%	-18.3%	-8.1%	-9.2%	-11.2%	-32.8%	-14.8%	-9.0%	-7.0%	7.9%	7.93%
Net Income 3Y	-0.3%	-18.1%	-29.4%	-29.5%	-35.7%	-18.8%	-22.7%	-23.3%	-30.2%	-27.9%	-26.7%	-30.1%	-11.2%	-4.9%	8.4%	-28.7%	24.5%	19.5%	24.7%	50.0%	50.03%
Net Income 5Y	1.5%	-9.9%	-16.6%	-18.8%	-25.3%	-17.1%	-12.0%	-12.1%	-15.8%	-15.0%	-15.2%	-18.5%	-8.3%	-9.4%	-11.4%	-33.1%	-15.1%	-9.8%	-8.0%	6.5%	6.53%
EBITDA 3Y	1.0%	-11.5%	-21.7%	-23.1%	-26.9%	-14.8%	-17.9%	-17.7%	-23.0%	-20.1%	-19.4%	-21.3%	-6.3%	-1.7%	7.0%	-13.5%	18.3%	10.8%	14.3%	29.9%	29.89%
EBITDA 5Y	1.0%	-9.1%	-13.7%	-16.1%	-19.9%	-14.3%	-9.1%	-8.3%	-10.4%	-8.0%	-9.1%	-11.2%	-4.1%	-6.3%	-8.4%	-22.1%	-11.8%	-9.9%	-8.6%	2.1%	2.09%
Gross Profit 3Y	3.1%	-1.4%	-6.2%	-8.2%	-9.0%	-5.3%	-5.7%	-3.5%	-5.7%	-4.7%	-5.4%	-8.0%	-1.6%	0.2%	3.4%	-0.0%	7.9%	7.9%	7.5%	13.8%	13.77%
Gross Profit 5Y	3.7%	0.3%	-1.6%	-4.0%	-6.0%	-5.2%	-2.2%	-0.9%	-1.5%	-0.4%	-1.6%	-3.1%	0.3%	0.0%	-0.8%	-4.6%	-2.6%	-1.9%	-1.9%	3.3%	3.33%
Op. Income 3Y	-0.4%	-15.5%	-27.4%	-28.3%	-34.7%	-17.1%	-23.1%	-24.7%	-30.9%	-26.8%	-24.2%	-26.8%	-8.9%	-4.1%	8.1%	-29.3%	18.9%	7.5%	15.4%	44.0%	44.00%
Op. Income 5Y	-1.0%	-12.5%	-18.8%	-21.1%	-26.8%	-19.0%	-14.2%	-14.3%	-16.6%	-13.2%	-12.1%	-14.5%	-5.6%	-7.3%	-11.2%	-33.7%	-17.6%	-15.3%	-12.7%	2.2%	2.19%
FCF 3Y	0.9%	-25.2%	—	—	—	—	-77.9%	—	-57.1%	-43.6%	-48.9%	-37.8%	-20.8%	-8.0%	—	—	—	—	4.5%	—	—
FCF 5Y	11.6%	-2.7%	—	—	—	—	—	—	-30.6%	-12.7%	-16.9%	-12.0%	-14.2%	-22.8%	-1.6%	-10.9%	0.9%	-8.2%	-5.2%	0.3%	0.32%
OCF 3Y	1.0%	-22.6%	-64.0%	—	-84.5%	—	-59.9%	-70.8%	-52.2%	-41.5%	-45.5%	-34.8%	-18.5%	-6.0%	1.9%	—	7.0%	—	2.0%	2.4%	2.37%
OCF 5Y	10.8%	-2.2%	-44.7%	—	-45.6%	—	—	-37.1%	-26.5%	-11.5%	-14.5%	-10.2%	-12.5%	-19.9%	-1.0%	-10.2%	1.1%	-7.8%	-5.0%	0.5%	0.46%
Assets 3Y	4.9%	4.3%	1.1%	1.4%	-0.2%	-0.6%	-0.6%	1.1%	-0.2%	0.4%	0.9%	-0.8%	0.5%	1.2%	3.3%	2.7%	3.7%	4.0%	4.3%	2.5%	2.52%
Assets 5Y	8.1%	8.3%	5.7%	3.7%	1.8%	1.2%	1.7%	2.6%	1.8%	3.0%	2.1%	2.4%	2.1%	2.2%	2.4%	1.7%	1.3%	0.4%	0.8%	0.1%	0.07%
Equity 3Y	4.6%	0.9%	0.3%	-0.9%	-2.5%	-2.5%	0.2%	0.1%	-1.7%	-1.7%	-1.3%	-1.2%	0.6%	3.4%	4.8%	2.9%	5.5%	6.2%	5.3%	4.8%	4.81%
Book Value 3Y	4.4%	1.0%	0.5%	-0.8%	-2.4%	-2.5%	0.3%	0.2%	-1.5%	-1.3%	-0.8%	-0.6%	1.1%	3.5%	5.0%	3.3%	5.9%	7.5%	6.9%	6.8%	6.80%
Dividend 3Y	0.7%	1.0%	0.9%	0.7%	0.6%	0.7%	-8.5%	-20.1%	-36.6%	-45.7%	-40.3%	-31.6%	-14.0%	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.03	0.01	0.00	0.03	0.32	0.80	0.91	0.84	0.79	0.76	0.73	0.62	0.48	0.35	0.23	0.10	0.00	0.09	0.39	0.74	0.736
Earnings Stability	0.04	0.17	0.10	0.27	0.48	0.54	0.32	0.45	0.58	0.58	0.60	0.72	0.50	0.49	0.45	0.78	0.39	0.22	0.08	0.02	0.017
Margin Stability	0.89	0.90	0.90	0.86	0.86	0.89	0.86	0.84	0.85	0.88	0.88	0.86	0.86	0.92	0.94	0.91	0.88	0.90	0.89	0.81	0.807
Rev. Growth Consistency	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	0.00	1.00	1.00	1.00	0.00	0.00	1.00	1.00	0.50	0.500
FCF Positive Streak	1	1	0	0	0	0	0	0	0	0	1	0	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.92	0.50	0.50	0.50	0.50	0.90	0.97	0.91	0.81	0.97	0.93	0.94	0.50	0.97	0.99	0.50	0.92	0.80	0.50	0.50	0.500
Earnings Smoothness	0.77	0.27	0.00	0.00	0.00	0.72	0.93	0.80	0.61	0.93	0.85	0.83	0.52	0.94	0.98	0.04	0.77	0.60	0.51	0.00	0.000
ROE Trend	-0.03	-0.07	-0.12	-0.11	-0.12	-0.07	-0.06	-0.04	-0.03	-0.01	0.01	-0.01	0.04	-0.00	-0.00	-0.05	-0.01	0.04	0.05	0.19	0.193
Gross Margin Trend	0.02	0.00	-0.02	-0.04	-0.04	-0.03	-0.02	-0.01	-0.00	0.01	0.02	0.00	0.02	0.01	0.00	-0.02	-0.01	-0.00	-0.00	0.06	0.056
FCF Margin Trend	-0.02	-0.07	-0.08	-0.10	-0.07	-0.08	-0.06	-0.04	-0.01	0.02	0.02	0.03	0.02	0.01	0.04	0.04	0.07	0.06	0.05	0.04	0.045
Sustainable Growth Rate	2.0%	-3.5%	-6.4%	-7.1%	-9.4%	-6.5%	-2.9%	1.0%	3.4%	6.1%	6.7%	4.5%	8.6%	8.3%	8.4%	2.3%	8.1%	11.7%	13.2%	24.7%	24.69%
Internal Growth Rate	1.2%	—	—	—	—	—	—	0.6%	2.0%	3.7%	4.2%	2.7%	5.4%	5.1%	5.4%	1.4%	5.2%	7.8%	9.0%	17.9%	17.86%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.14	0.81	0.11	-0.43	0.02	-0.24	0.16	0.11	0.55	1.17	0.83	1.39	0.88	0.78	2.04	8.95	4.12	2.45	2.37	1.28	1.279
FCF/OCF	0.93	0.85	-0.82	1.48	-16.75	1.64	0.16	-0.15	0.70	0.88	0.80	0.84	0.86	0.79	0.93	0.94	0.96	0.96	0.97	0.96	0.963
FCF/Net Income	snapshot only																				1.232
OCF/EBITDA	snapshot only																				1.044
CapEx/Revenue	0.3%	0.3%	0.4%	0.4%	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	0.4%	0.4%	0.4%	0.4%	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	0.31%
CapEx/Depreciation	snapshot only																				0.727
Accruals Ratio	-0.01	0.01	0.04	0.05	0.03	0.06	0.04	0.04	0.02	-0.01	0.01	-0.02	0.01	0.01	-0.05	-0.11	-0.15	-0.11	-0.11	-0.04	-0.042
Sloan Accruals	snapshot only																				0.067
Cash Flow Adequacy	snapshot only																				27.369
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	3.5%	5.0%	4.7%	5.0%	7.1%	7.1%	4.6%	2.9%	2.1%	1.3%	1.1%	1.3%	1.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.83	$0.84	$0.84	$0.84	$0.85	$0.85	$0.64	$0.43	$0.21	$0.14	$0.14	$0.14	$0.14	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	86.7%	1.4%	1.9%	2.1%	3.1%	1.8%	1.4%	87.6%	52.3%	27.0%	24.6%	32.7%	19.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	81.7%	2.0%	—	—	—	—	52.3%	—	1.3%	26.3%	36.8%	27.9%	26.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	94.2%	1.8%	2.6%	2.8%	3.8%	1.8%	1.4%	93.7%	72.6%	57.5%	49.4%	75.4%	40.0%	15.3%	29.1%	1.5%	1.1%	1.0%	1.2%	74.6%	74.64%
Div. Increase Streak	1	1	1	1	1	1	0	0	0	0	0	0	0	—	—	—	—	—	—	—	—
Chowder Number	0.06	0.07	0.07	0.07	0.09	0.09	-0.19	-0.46	-0.73	-0.83	-0.78	-0.67	-0.36	—	—	—	—	—	—	—	—
Buyback Yield	0.3%	1.7%	1.6%	1.6%	1.8%	0.0%	0.2%	0.2%	0.8%	1.5%	1.1%	1.7%	1.2%	0.7%	1.6%	1.5%	3.5%	4.5%	6.0%	5.3%	5.30%
Net Buyback Yield	0.3%	1.7%	1.6%	1.6%	1.8%	-0.0%	0.2%	0.2%	0.8%	1.5%	1.1%	1.7%	1.2%	0.7%	1.6%	1.5%	3.5%	4.5%	5.8%	5.2%	5.22%
Total Shareholder Return	3.8%	6.7%	6.3%	6.5%	8.9%	7.1%	4.8%	3.1%	2.9%	2.8%	2.2%	3.0%	2.4%	0.7%	1.6%	1.5%	3.5%	4.5%	5.8%	5.2%	5.22%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.75	0.74	0.73	0.79	0.77	0.77	0.77	0.76	0.76	0.72	0.72	0.71	0.72	0.75	0.75	0.69	0.73	0.87	0.86	0.81	0.812
Interest Burden (EBT/EBIT)	0.99	0.98	0.97	0.96	0.93	0.94	0.91	0.89	0.84	0.86	0.87	0.84	0.90	0.89	0.92	0.82	0.96	0.98	0.99	1.06	1.061
EBIT Margin	0.06	0.04	0.03	0.02	0.02	0.03	0.03	0.03	0.03	0.04	0.04	0.03	0.04	0.03	0.03	0.01	0.03	0.04	0.04	0.08	0.077
Asset Turnover	2.13	2.08	2.17	2.17	2.23	2.25	2.29	2.23	2.27	2.20	2.20	2.16	2.19	2.12	2.14	2.21	2.25	2.26	2.26	2.30	2.298
Equity Multiplier	1.64	1.69	1.63	1.68	1.68	1.71	1.65	1.69	1.71	1.72	1.66	1.69	1.67	1.69	1.65	1.69	1.64	1.61	1.59	1.63	1.630

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$0.95	$0.62	$0.44	$0.40	$0.28	$0.47	$0.47	$0.49	$0.41	$0.50	$0.55	$0.41	$0.68	$0.53	$0.56	$0.15	$0.54	$0.82	$0.96	$1.74	$1.74
Book Value/Share	$6.40	$6.09	$6.01	$5.89	$5.68	$5.73	$5.91	$6.04	$5.94	$6.18	$6.41	$6.38	$6.61	$6.76	$6.95	$6.50	$6.75	$7.12	$7.23	$7.36	$7.49
Tangible Book/Share	$5.30	$4.80	$4.73	$4.63	$4.43	$4.50	$4.70	$4.85	$4.75	$4.99	$5.23	$5.21	$5.45	$5.61	$5.73	$5.30	$5.56	$5.91	$6.02	$5.96	$5.96
Revenue/Share	$21.91	$22.09	$22.35	$22.70	$22.69	$22.73	$22.55	$22.46	$22.48	$22.62	$22.65	$22.81	$23.02	$23.19	$23.52	$24.14	$24.60	$25.65	$26.07	$26.46	$26.90
FCF/Share	$1.01	$0.42	$-0.04	$-0.26	$-0.07	$-0.18	$0.01	$-0.01	$0.16	$0.52	$0.37	$0.49	$0.51	$0.33	$1.06	$1.24	$2.15	$1.94	$2.19	$2.15	$2.19
OCF/Share	$1.08	$0.50	$0.05	$-0.17	$0.00	$-0.11	$0.08	$0.06	$0.23	$0.59	$0.46	$0.58	$0.60	$0.42	$1.14	$1.32	$2.23	$2.02	$2.27	$2.23	$2.27
Cash/Share	$2.73	$2.49	$1.88	$1.74	$1.53	$1.63	$1.50	$1.63	$1.63	$2.00	$1.75	$1.77	$1.40	$1.84	$1.55	$2.23	$2.41	$2.85	$2.51	$2.85	$2.90
EBITDA/Share	$1.48	$1.05	$0.83	$0.73	$0.59	$0.85	$0.87	$0.92	$0.84	$1.00	$1.07	$0.90	$1.23	$1.00	$1.02	$0.48	$0.99	$1.20	$1.36	$2.14	$2.14
Debt/Share	$0.16	$0.24	$0.28	$0.27	$0.45	$0.45	$0.58	$0.69	$0.76	$0.59	$0.68	$0.55	$0.46	$0.22	$0.11	$0.21	$0.27	$0.34	$0.21	$0.25	$0.25
Net Debt/Share	$-2.58	$-2.25	$-1.61	$-1.47	$-1.07	$-1.19	$-0.92	$-0.94	$-0.87	$-1.41	$-1.07	$-1.22	$-0.94	$-1.61	$-1.44	$-2.03	$-2.14	$-2.50	$-2.31	$-2.60	$-2.60

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7.407
Altman Z-Prime	snapshot only																				11.546
Piotroski F-Score	4	3	3	3	4	3	6	5	4	6	5	5	7	6	8	6	8	8	8	8	8
Beneish M-Score	-2.34	-1.91	-1.81	-1.73	-1.98	-2.25	-2.35	-2.41	-2.31	-2.51	-2.28	-2.17	-2.59	-2.23	-2.72	4.41	-3.51	-3.24	-3.19	-3.24	-3.240
Ohlson O-Score	snapshot only																				-9.837
ROIC (Greenblatt)	snapshot only																				34.77%
Net-Net WC	snapshot only																				$3.78
EVA	snapshot only																				$72926298.50

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AAA
Credit Score	96.35	96.55	89.29	87.63	85.67	86.36	88.07	83.66	86.22	90.12	90.16	87.66	93.26	90.67	93.60	87.97	95.94	96.31	95.92	96.08	96.081
Credit Grade	snapshot only																				1
Credit Trend	snapshot only																				8.107
Implied Spread (bps)	snapshot only																				50.000
Industry Credit Rank	snapshot only																				91
Sector Credit Rank	snapshot only																				93

HCSG NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet